610
M. K. Mehra et al.
Letter
Synlett
(12) Merritt, E. A.; Olofsson, B. Angew. Chem. Int. Ed. 2009, 48, 9052.
(13) Zhdankin, V. V.; Stang, P. J. Chem. Rev. 2008, 108, 5299.
(14) Bellina, F.; Rossi, R. Tetrahedron 2009, 65, 10269.
(15) Yusubov, M. S.; Maskaev, A. V.; Zhdankin, V. V. ARKIVOC 2011,
(i), 370.
(16) Sun, C.-L.; Shi, Z.-J. Chem. Rev. 2014, 114, 9219.
(17) Ackermann, L.; Dell’Acqua, M.; Fenner, S.; Vicente, R.;
Sandmann, R. Org. Lett. 2011, 13, 2358.
R2
R2
O
O
N
Br
PdCl2
Et3N, 90 °C, 4 h
N
8g–i
9
(18) Umierski, N.; Manolikakes, G. Org. Lett. 2013, 15, 188.
(19) Jalalian, N.; Ishikawa, E. E.; Silva, L. F.; Olofsson, B. Org. Lett.
2011, 13, 1552.
Cl
OMe
(20) Lindstedt, E.; Ghosh, R.; Olofsson, B. Org. Lett. 2013, 15, 6070.
(21) Ghosh, R.; Olofsson, B. Org. Lett. 2014, 16, 1830.
(22) Thorat, P. B.; Waghmode, N. A.; Karade, N. N. Tetrahedron Lett.
2014, 55, 5718.
(23) Kumar, D.; Arun, V.; Pilania, M.; Shekar, K. Synlett 2013, 24, 831.
(24) Kumar, D.; Pilania, M.; Arun, V.; Pooniya, S. Org. Biomol. Chem.
2014, 12, 6340.
O
N
O
O
N
N
9a, 83%
9b, 80%
9c, 82%
(25) Bielawski, M.; Aili, D.; Olofsson, B. J. Org. Chem. 2008, 73, 4602.
(26) Bielawski, M.; Olofsson, B. Chem. Commun. 2007, 2521.
(27) Chun, J.-H.; Lu, S.; Pike, V. W. Eur. J. Org. Chem. 2011, 2011, 4439.
(28) Jayashree, B. S.; Thomas, S.; Nayak, Y. Med. Chem. Res. 2010, 19,
193.
Scheme 3 Synthesis of benzofuro[3,2-c]quinolines 9
Acknowledgment
(29) Huang, L.-J.; Hsieh, M.-C.; Teng, C.-M.; Lee, K.-H.; Kuo, S.-C.
Bioorg. Med. Chem. 1998, 6, 1657.
Financial support from the DBT, New Delhi is gratefully acknowl-
edged. M.K.M. thanks the CSIR, New Delhi for the award of Junior Re-
search Fellowship.
(30) Synthesis of Aryloxyquinolines; General Procedure:
A
mixture of quinolone (0.62 mmol), diaryliodonium salt (0.62
mmol) and potassium carbonate (260 mg, 1.88 mmol) in
toluene (1 mL) or DMF (2–3 drops) was irradiated in a CEM Dis-
cover MW reactor (100 W power) at 100 °C for 5 min. Upon
completion of the reaction, as indicated by TLC, solvent was
removed and the residue was dissolved in dichloromethane (20
mL). To this solution, water (20 mL) was added and the mixture
stirred at room temperature for 10 min. The organic phase was
separated, washed with brine (2 × 15 mL), dried over anhydrous
Na2SO4, filtered, and concentrated in vacuo. The crude product
thus obtained was purified by silica gel (100–200) column chro-
matography to afford the pure aryloxyquinoline.
Supporting Information
Supporting information for this article is available online at
S
u
p
p
ortiInfogrmoaitn
S
u
p
p
ortioInfgrmoaitn
References and Notes
(1) Janz, K.; Kaila, N. J. Org. Chem. 2009, 74, 8874.
(2) Falke, H.; Chaikuad, A.; Becker, A.; Loaëc, N.; Lozach, O.; Abu
Jhaisha, S.; Becker, W.; Jones, P. G.; Preu, L.; Baumann, K.;
Knapp, S.; Meijer, L.; Kunick, C. J. Med. Chem. 2015, 58, 3131.
(3) Korotchenko, V.; Sathunuru, R.; Gerena, L.; Caridha, D.; Li, Q.;
Kreishman-Deitrick, M.; Smith, P. L.; Lin, A. J. J. Med. Chem.
2015, 58, 3411.
(4) Soares, R. R.; da Silva, J. M. F.; Carlos, B. C.; da Fonseca, C. C.; de
Souza, L. S. A.; Lopes, F. V.; de Paula Dias, R. M.; Moreira, P. O. L.;
Abramo, C.; Viana, G. H. R.; de Pila Varotti, F.; da Silva, A. D.;
Scopel, K. K. G. Bioorg. Med. Chem. Lett. 2015, 25, 2308.
(5) Medapi, B.; Renuka, J.; Saxena, S.; Sridevi, J. P.; Medishetti, R.;
Kulkarni, P.; Yogeeswari, P.; Sriram, D. Bioorg. Med. Chem. 2015,
23, 2062.
(6) Pandey, A. K.; Sharma, R.; Shivahare, R.; Arora, A.; Rastogi, N.;
Gupta, S.; Chauhan, P. M. S. J. Org. Chem. 2013, 78, 1534.
(7) Cai, Z.; Zhou, W.; Pan, J.; Hao, Q.; Zhang, L. J. Chin. Pharm. Sci.
2010, 19, 15.
(8) Ries, U. J.; Priepke, H. W.; Hauel, N. H.; Haaksma, E. E.; Stassen, J.
M.; Wienen, W.; Nar, H. Bioorg. Med. Chem. Lett. 2003, 13, 2291.
(9) Qi, B.; Mi, B.; Zhai, X.; Xu, Z.; Zhang, X.; Tian, Z.; Gong, P. Bioorg.
Med. Chem. 2013, 21, 5246.
4-Methyl-2-phenoxyquinoline (6a): Yield: 119 mg (81%); off-
white solid; mp 76–77 °C. 1H NMR (400 MHz, CDCl3): δ = 7.94
(dd, J = 8.3, 1.2 Hz, 1 H), 7.80 (dd, J = 8.4, 0.7 Hz, 1 H), 7.66–7.62
(m, 1 H), 7.56–7.53 (m, 2 H), 7.50–7.46 (m, 1 H), 7.28 (s, 1 H),
7.18–7.15 (m, 2 H), 6.96 (d, J = 0.9 Hz, 1 H), 2.71 (s, 3 H).
13C NMR (101 MHz, CDCl3): δ = 161.0, 153.0, 148.5, 146.2, 132.5,
129.7, 128.4, 126.0, 124.9, 123.7, 123.3, 117.3, 112.7, 18.9. IR
(KBr): 1612, 1574, 1512, 1481, 1381, 1342, 1219, 825, 756 cm–1
.
MS (ESI): m/z [M + H]+ calcd for C16H17NO: 236.1; found: 236.2.
4-Phenoxyquinoline(8a): Yield: 122 mg (80%); yellow liquid.
1H NMR (400 MHz, CDCl3): δ = 8.68 (d, J = 5.2 Hz, 1 H), 8.44–
8.33 (m, 1 H), 8.12 (d, J = 8.5 Hz, 1 H), 7.78–7.73 (m, 1 H), 7.59–
7.55 (m, 1 H), 7.49–7.44 (m, 2 H), 7.33–7.27 (m, 1 H), 7.22–7.16
(m, 2 H), 6.55 (d, J = 5.2 Hz, 1 H). 13C NMR (101 MHz, CDCl3): δ =
161.9, 154.4, 151.1, 149.7, 130.3, 130.1, 129.0, 126.1, 125.6,
121.8, 121.5, 121.1, 104.3. IR (KBr): 1566, 1489, 1420, 1389,
. MS (ESI): m/z [M +
1304, 1211, 771 cm–1 H]+ calcd for
C
15H12NO: 222.0; found: 222.1.
(31) David, E.; Pellet-Rostaing, S.; Lemaire, M. Tetrahedron 2007, 63,
8999.
(10) Maiti, D.; Buchwald, S. L. J. Org. Chem. 2010, 75, 1791.
(11) Zhao, J.; Peng, C.; Liu, L.; Wang, Y.; Zhu, Q. J. Org. Chem. 2010, 75,
7502.
(32) Chen, Y.-L.; Chung, C.-H.; Chen, I.-L.; Chen, P.-H.; Jeng, H.-Y.
Bioorg. Med. Chem. 2002, 10, 2705.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2016, 27, 604–610